Health
UNDERREPORTED
FDA Opens Applications for Pilot to Accelerate Human Drug Testing
The FDA announced it will accept applications for a pilot program aimed at shortening the time needed for drug developers to start human trials.
The agency launched the initiative as part of Operation TrialBlazer, a Health and Human Services effort to speed up drug approvals. Officials said the U.S. process can take years, while rivals such as China and Australia complete it in months. The pilot seeks to reduce these timelines for participating companies. Applications are now being accepted, with the goal of enhancing U.S. competitiveness in biotechnology.
Why it matters
Faster trial start dates could speed access to new medicines and keep U.S. biotech firms competitive internationally.
In this story
FDAdrug approvalhuman trialsOperation TrialBlazerbiotechnologyregulatory pilotU.S. competitiveness
